Olatunde Fatinikun, MD
Child & Adolescent Psychiatry · Seffner, FLNPI 1942383450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 475 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,808 and has fallen 60.8% since, to $709 in 2025. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 475 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$669
- Supernus Pharmaceuticals, Inc.$659
- AbbVie$625
- Sunovion Pharmaceuticals Inc.$604
- Ironshore Pharmaceuticals Inc.$557
- plus $3K from 27 others
What the payments were for
- Consulting fees$2003%
- Food & beverage$7,42097%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 85 | $1,209 |
| Johnson & Johnson | 34 | $669 |
| Supernus Pharmaceuticals, Inc. | 39 | $659 |
| AbbVie(2 entities) | 37 | $625 |
| Sunovion Pharmaceuticals Inc. | 50 | $604 |
| Ironshore Pharmaceuticals Inc. | 35 | $557 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $351 |
| Lundbeck LLC | 18 | $333 |
| Neos Therapeutics, LP | 19 | $261 |
| Tris Pharma Inc | 19 | $258 |
| Neuronetics, Inc. | 7 | $218 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Alkermes, Inc. | 11 | $196 |
| Vanda Pharmaceuticals Inc. | 9 | $192 |
| Corium, LLC | 9 | $134 |
| Vertical Pharmaceuticals, LLC | 10 | $131 |
| Axsome Therapeutics, Inc. | 5 | $121 |
| Adlon Therapeutics L.p. | 7 | $109 |
| E.r. Squibb & Sons, L.L.C. | 5 | $103 |
| Eisai Inc. | 6 | $98 |
| Jazz Pharmaceuticals Inc. | 6 | $90 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $74 |
| Avanir Pharmaceuticals, Inc. | 4 | $72 |
| Tempus AI, Inc | 3 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Indivior Inc. | 3 | $47 |
| Shire North American Group Inc | 3 | $45 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Almatica Pharma LLC | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Bausch Health US, LLC | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$325
- NEUROSTAR TMS THERAPY$158
How this compares
$7,638 in reported general payments places this provider in the 90th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 18 | $56,896 |
| VraylarCariprazine Hcl | 22 | $31,479 |
| Lurasidone Hcl | 17 | $16,148 |
| SpravatoEsketamine Hcl | 11 | $12,379 |
| VyvanseLisdexamfetamine Dimesylate | 23 | $8,863 |
| Lisdexamfetamine Dimesylate | 23 | $6,199 |
| ConcertaMethylphenidate Hcl | 11 | $4,376 |
| DayvigoLemborexant | 14 | $4,238 |
| Aripiprazole | 38 | $2,810 |
| Clozapine | 50 | $2,683 |
| Bupropion XlBupropion Hcl | 101 | $2,510 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 44 | $2,471 |
| Risperidone OdtRisperidone | 14 | $2,457 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 80 | $1,575 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 40 | $1,208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Spravato, Concerta | $669 | $73,65140 claims |
| AbbVieVraylar | $625 | $31,47922 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $351 | $8,86323 claims |
| Eisai Inc.Dayvigo | $98 | $4,23814 claims |
| Almatica Pharma LLCSertraline Hcl | $34 | $63374 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 206 child & adolescent psychiatry providers in Florida.
Other child & adolescent psychiatry in Seffner
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
- Bhaskar RajuOrlando$11K
- Americo PadillaMiami$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.